Definitive Healthcare (NASDAQ:DH) Issues Q3 Earnings Guidance

Definitive Healthcare (NASDAQ:DH) updated its third quarter earnings guidance on Monday. The company provided earnings per share guidance of $0.07-0.08 for the period, compared to the consensus earnings per share estimate of $0.09. The company issued revenue guidance of $61.0-62.5 million, compared to the consensus revenue estimate of $63.51 million.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on DH shares. Deutsche Bank Aktiengesellschaft cut their target price on shares of Definitive Healthcare from $10.00 to $7.00 and set a hold rating for the company in a research report on Thursday, May 9th. Barclays decreased their target price on Definitive Healthcare from $7.00 to $6.00 and set an equal weight rating on the stock in a report on Wednesday, July 31st. Needham & Company LLC restated a hold rating on shares of Definitive Healthcare in a research report on Tuesday. JPMorgan Chase & Co. cut Definitive Healthcare from a neutral rating to an underweight rating and lowered their price objective for the company from $7.00 to $5.00 in a research report on Wednesday, July 31st. Finally, Stifel Nicolaus decreased their target price on shares of Definitive Healthcare from $9.50 to $7.50 and set a buy rating on the stock in a research note on Wednesday, July 31st. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the company. According to MarketBeat, Definitive Healthcare has an average rating of Hold and an average target price of $8.05.

Definitive Healthcare Stock Up 4.7 %

NASDAQ DH traded up $0.17 during trading on Wednesday, reaching $3.82. 1,630,689 shares of the company’s stock traded hands, compared to its average volume of 818,265. The firm has a market cap of $450.51 million, a price-to-earnings ratio of -2.09, a price-to-earnings-growth ratio of 4.58 and a beta of 1.30. Definitive Healthcare has a 12-month low of $3.19 and a 12-month high of $11.44. The company has a debt-to-equity ratio of 0.20, a current ratio of 2.30 and a quick ratio of 2.30. The company’s 50 day simple moving average is $5.37 and its two-hundred day simple moving average is $6.96.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings data on Monday, August 5th. The company reported $0.09 EPS for the quarter, meeting the consensus estimate of $0.09. Definitive Healthcare had a positive return on equity of 0.51% and a negative net margin of 78.16%. The firm had revenue of $63.70 million during the quarter, compared to analyst estimates of $63.19 million. During the same quarter in the prior year, the business posted $0.08 EPS. The business’s revenue for the quarter was up 4.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Definitive Healthcare will post 0.09 EPS for the current fiscal year.

Definitive Healthcare Company Profile

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.